June 30th 2025
Pediatricians offer anecdotal evidence in ACIP deliberations as vaccine skepticism grows under RFK Jr.
June 27th 2025
Vaccines become center of the medical world as ACIP meets to advise CDC.
June 26th 2025
RFK-appointed panel approves vaccines for babies, youths and adults in its first official meeting.
Vaccine supporters say science is on their side, but others want more research and better guidance on getting inoculated against illness.
June 25th 2025
Medical organizations publish open letter to American public as new ACIP panel meets with new members.
Cases and Conversations™: Applying Best Practices to Prevent Shingles in Your Practice
View More
CDC recommends Pfizer COVID-19 vaccine for children 5 to 11
The agency moved quickly to approve the smaller shots.
FDA authorizes COVID-19 vaccine for children aged 5 to 11
The vaccine is just awaiting a recommendation from the CDC before they can be rolled out.
FDA panel recommends Pfizer COVID-19 vaccine for children
A previous analysis found the vaccine was 90.7 percent effective against severe COVID-19.
Pfizer touts efficacy of COVID-19 vaccine in ages 5 to 11
The FDA is expected to act on an EUA application for the smaller doses next week.
White House lays out primary care’s role in juvenile COVID-19 vaccinations
The administration sees pediatricians and primary care physicians taking the lead in the push.
FDA expected to allow mix and match COVID-19 boosters
The agency is expected to decide on that as well as Moderna and Johnson and Johnson boosters this week.
UPDATED: FDA recommends Moderna, Johnson and Johnson COVID-19 boosters
The advisory panel is also scheduled to discuss Merck antiviral pill late next month.
FDA panel discussing Moderna COVID-19 boosters
A recommendation is expected on whether the shot should be authorized.
White House report: COVID-19 vaccine mandates working
The Biden administration says that vaccination mandates are not leading to the mass resignations in health that some expected.
Pfizer submits application for child COVID-19 vaccine EUA
The drug has proven effective in patients between 5 and 11 years old, according to Pfizer.
Survey: Uptick in COVID-19 vaccination tied to Delta, hospitalizations, deaths
The leading causes of the bump in COVID-19 vaccination are tied to the impact of the disease.
CDC gives go ahead to Pfizer COVID-19 boosters
CDC Director Walensky overrode an agency panel to recommend the shots for healthcare workers.
FDA authorizes Pfizer boosters for patients over 65, at high risk of COVID-19
The agency did not recommend the additional shots for the general public.
Johnson and Johnson COVID-19 booster proves effective
A study shows an additional dose of the vaccine gives the patient 94 percent protection against symptomatic COVID-19 in the U.S.
UPDATE: FDA committee votes against COVID-19 boosters for most
The Vaccines and Related Biological Products Advisory Committee voted against recommending the extra shots for the general public.
ACP gives employers, others greenlight on vaccine mandates
The organization says the government’s requirements are appropriate.
FDA sets meeting for Pfizer COVID-19 booster authorization
The Vaccines and Related Biological Products Advisory Committee will meet Sept. 17.
Report: Vaccination rates rise as Delta sweeps the U.S.
August saw a rise in COVID-19 vaccination rates as people seek to avoid the more transmissible Delta variant.
How many lives have been saved by COVID-19 vaccinations in the U.S.?
While the vaccine rollout has snagged, the effort has already saved thousands.
Johnson and Johnson: Second dose of COVID-19 vaccine boosts antibodies
Trials have shown a booster of the single-dose vaccine produces a robust increase in spike-binding antibodies.
AAP warns against off-label COVID-19 vaccination for patients under 12
The organization says the medical community should wait for results from the clinical trials for vaccinating patients under 12.
COVID-19 boosters to be offered starting Sept. 20
The Biden administration will make the additional doses of two COVID-19 vaccines available to combat the Delta variant.
AAFP calls for FDA authorization of children’s COVID-19 shots
The organization wants the current emergency use authorization to be expanded to include patients under 12.
Biden administration to advise all get COVID-19 boosters
The rollout of the boosters is expected to follow a similar track to that used in the first round of immunizations.
FDA expected to authorize COVID-19 boosters for the immunocompromised
The authorization would cover both the Pfizer and Moderna vaccines.
Study: Flu shot offers protection against COVID-19
The flu shot was shown to reduce the number of patients with COVID-19 who required treatment from an emergency department or the intensive care unit.
What’s driving vaccine denial?
A Polish study found that most vaccine deniers offer only a vague reasoning for avoiding the shots.
WHO pushes moratorium on COVID-19 booster shots
The organization cites a lack of data and says nations should prioritize vaccinating more of the world’s population before turning to boosters.
Report: FDA to give Pfizer COVID-19 vaccine final approval soon
The move is expected to clear the way for more vaccine mandates.
AMA releases provisional CPT code for third dose of Pfizer COVID-19 vaccine
As additional vaccinations may become necessary this code will ensure physicians can get paid.